Ribeiro, Filipe Moura
Ribeiro, Camila Fontoura Acosta
de Souza Cândido, Elizabete
Buccini, Danieli Fernanda
Cardoso, Marlon Henrique
Greice de Oliveira Silva Silveira, Gislaine
de Souza, Carolina Moura
Silva, Osmar Nascimento
de Andrade, Gisele Braziliano
da Silva, Alanderson Rodrigues
da Mota, Franciele Bathel
Makimoto, Sarah Saory
dos Santos Ferreira, Rosangela
de Oliveira, Nathália Cavichiolli
de Castro, Alinne Pereira
Carvalho, Cristiano Marcelo Espínola
de la Fuente-Nunez, Cesar
Franco, Octávio Luiz
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Fundação de Apoio à Pesquisa do Distrito Federal
Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul
Financiadora de Estudos e Projetos
Article History
Received: 18 January 2025
Accepted: 9 June 2025
First Online: 30 June 2025
Competing interests
: Cesar de la Fuente-Nunez is a co-founder of, and scientific advisor, to Peptaris, Inc., provides consulting services to Invaio Sciences, and is a member of the Scientific Advisory Boards of Nowture S.L., Peptidus, European Biotech Venture Builder, the Peptide Drug Hunting Consortium (PDHC), ePhective Therapeutics, Inc., and Phare Bio. Dr. de la Fuente-Nunez serves as Guest Editor of this journal and had no role in the peer review or decision to publish this manuscript. All other authors declare no competing interests.